Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into 6 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
William A. Paxton
William A. Paxton, PhD DIC, is an Associate Professor in the Laboratory of Experimental Virology at the Academic Medical Center, University of Amsterdam, the Netherlands. Dr Paxton obtained his PhD from the Biochemistry Department, Imperial College of Science Technology and Medicine, University of London, UK, in the field of molecular parasitology and studying immune responses against filarial nematode antigens. His postdoctoral period was undertaken at the Aaron Diamond AIDS Research Center, New York, USA with Richard Koup, during which period his research focused on identifying and studying individuals highly exposed to HIV-1 but who remained uninfected. Since moving to Amsterdam his research has focused on better understanding the molecular interactions between HIV-1 and the array of (co)receptors it interacts with and which can facilitate infection. His lab has also identified and characterized novel host factors which can interfere with viral transmission and/or disease progression. More recently he interest has been in studying the role of HIV-1 in the context of bacterial or parasitic co-infections.
Teunis B.H. Geijtenbeek
Teunis B.H. Geijtenbeek is a Professor of Cellular and Molecular Immunology at the Academic Medical Center in Amsterdam, the Netherlands. His laboratory studies the molecular mechanisms of dendritic cell-pathogen interactions that shape adaptive immunity or promote infection. He focuses on the function of C-type lectin receptors expressed by human dendritic cell subsets in adaptive immunity to HIV-1 and M. tuberculosis, as well as HIV-1 transmission.